EUVIMEDEUVIMED entdecken
Open Access

Primary Human Breast Cancer‐Associated Endothelial Cells Favor Interactions with Nanomedicines

Lin Wang, Vinit Sheth, Kaili Liu, Prasanta Panja, Alex N Frickenstein, Yuxin He, Wen Yang, Abigail G Thomas, Mohammad Hasan Jamei, Jeesoo Park, Shanxin Lyu, Nathan D Donahue und 4 weitere

Advanced Materials · 2024-07 · 36 (28)

DOI: 10.1002/adma.202403986 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 03.05.2024. Verfasst von Lin Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, 73019, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Endothelial Cells, Nanoparticles, Nanomedicine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Oklahoma Center for the Advancement of Science and Technology, University of Oklahoma: OVPRP Postdoc Match Program and Strategic Equipment Investment Program (SEIP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer nanomedicines predominately rely on transport processes controlled by tumor‐associated endothelial cells to deliver therapeutic and diagnostic payloads into solid tumors. While the dominant role of this class of endothelial cells for nanoparticle transport and tumor delivery is established in animal models, the translational potential in human cells needs exploration. Using primary human breast cancer as a model, the differential interactions of normal and tumor‐associated endothelial cells with clinically relevant nanomedicine formulations are explored and quantified. Primary human breast cancer‐associated endothelial cells exhibit up to ≈2 times higher nanoparticle uptake than normal human mammary microvascular endothelial cells. Super‐resolution imaging studies reveal a significantly higher intracellular vesicle number for tumor‐associated endothelial cells, indicating a substantial increase in cellular transport activities. RNA sequencing and gene expression analysis indicate the upregulation of transport‐related genes, especially motor protein genes, in tumor‐associated endothelial cells. Collectively, the results demonstrate that primary human breast cancer‐associated endothelial cells exhibit enhanced interactions with nanomedicines, suggesting a potentially significant role for these cells in nanoparticle tumor delivery in human patients. Engineering nanoparticles that leverage the translational potential of tumor‐associated endothelial cell‐mediated transport into human solid tumors may lead to the development of safer and more effective clinical cancer nanomedicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsEndothelial CellsNanoparticlesNanomedicineHumansFemale

Stichwörter der Autor:innen

breast cancerendocytosisendothelial cellsnanomedicinenanoparticlesolid tumorstransport

Autor:innen und Institutionen

  • Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, 73019, USA.
  • Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.
  • Institute for Biomedical Engineering, Science and Technology (IBEST), Norman, OK, 73019, USA.

ORCID-Profile: Stefan Wilhelm

Förderung

  • NCI NIH HHS
  • Oklahoma Center for the Advancement of Science and Technology
  • University of Oklahoma: OVPRP Postdoc Match Program and Strategic Equipment Investment Program (SEIP)
  • National Science Foundation
  • NIGMS NIH HHS
  • NIH HHS
  • Directorate for Computer and Information Science and Engineering
  • National Institutes of Health

Zitieren

APA

Wang, L., Sheth, V., Liu, K., Panja, P., Frickenstein, A. N., He, Y., Yang, W., Thomas, A. G., Jamei, M. H., Park, J., Lyu, S., Donahue, N. D., Chen, W. R., Bhattacharya, R., Mukherjee, P., & Wilhelm, S. (2024). Primary Human Breast Cancer‐Associated Endothelial Cells Favor Interactions with Nanomedicines. Advanced Materials, 36(28). https://doi.org/10.1002/adma.202403986

Vancouver

Wang L, Sheth V, Liu K, Panja P, Frickenstein AN, He Y, et al. Primary Human Breast Cancer‐Associated Endothelial Cells Favor Interactions with Nanomedicines. Advanced Materials. 2024;36(28). doi:10.1002/adma.202403986

BibTeX
@article{Wang2024,
  author = {Wang, Lin and Sheth, Vinit and Liu, Kaili and Panja, Prasanta and Frickenstein, Alex N and He, Yuxin and Yang, Wen and Thomas, Abigail G and Jamei, Mohammad Hasan and Park, Jeesoo and Lyu, Shanxin and Donahue, Nathan D and Chen, Wei R and Bhattacharya, Resham and Mukherjee, Priyabrata and Wilhelm, Stefan},
  title = {Primary Human Breast Cancer‐Associated Endothelial Cells Favor Interactions with Nanomedicines},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {28},
  doi = {10.1002/adma.202403986}
}
Kostenlos starten →